LISTEN: Investors are betting $3.3 billion that your gut is the next frontier for the hottest part of healthcare
Samantha Lee/Business Insider
- Several high-profile startups that promised to draw insights from the bacteria living in and on us, known as the microbiome, have failed in recent months.
- One of them, a company called uBiome, which was valued at $600 million, said it would shut down on October 1 after months of challenges and setbacks.
- But investors still see the microbiome as a lucrative opportunity for the burgeoning digital-health industry, which has raked in $37.6 billion from investors since 2011.
- Here's how the microbiome companies they're betting on plan to succeed.
- Listen to this story below, or read it in full right here.
NOW WATCH: Why plane tires don't explode during landing
Popular on BI
- Girish Mathrubootham, the son of a retired bank officer who built a $13 billion company in just 10 years
- A couple who traveled to 48 states in an RV share 17 things they would never go on a trip without
- The Taliban is bringing back executions and cutting off hands as punishment after retaking control of Afghanistan
- DC vs RR: Who will win today’s IPL match?
- We asked three spacetech entrepreneurs what it takes to enter the field and they listed out the opportunities
- Ethereum’s scaling issues strike again as TIME Magazine’s NFTs sell for 30 times their price
- Best baby swing cradle and chair in India
- China's FUD drags down Bitcoin, Ether and other cryptocurrencies yet again